Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Prescient Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Sophisticated and professional investors line up to give Prescient Therapeutics cash
Health & Biotech
Health Kick Podcast: Chemo’s diminishing role, the ‘personalised’ approach to cancer treatment and PTX’s CAR-T innovations
Health & Biotech
Prescient partners with global cancer heavyweight to develop new treatments
Health & Biotech
Prescient gears up for growth with $6.5m raise as the race to cure cancer heats up
Health & Biotech
Prescient, Antisense the only green shoots in a sea of red
News
ASX Small Cap Lunch Wrap: Who’s teaching an old dog new tricks today?
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Biotech: Bugkiller Bio-gene closes a $2.4m funding round as it eyes off new revenue streams
News
Lunchtime ASX Small Cap Wrap: Who’s afraid of the D-word today?
Health & Biotech
Cancer clinical trials continue as others are shut down on COVID-19 fears
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
Health: PainChek reveals exactly how much its grown in 2019; and says there’s more to come next year
News
Trading Places: Here are this week’s substantial holder movements
Health & Biotech
Check up: Here’s what’s happening with ASX small cap health stocks
Health & Biotech
